Results for “ ”

Entry Author Date Location
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto 01/07/20 San Diego
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic 01/07/20 Boston
BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic 01/07/20 San Diego
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
China’s CF PharmTech Raises $90M to Advance Respiratory Drug Development 01/06/20 National
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger 01/03/20 San Diego
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health 01/02/20 National
Rexgenero CEO Talks Importance of “Dialogue” in Cell Therapy Conversations 01/02/20 National
Wave’s Huntington’s Drug Disappoints in Clinical Trial, Stock Sinks 01/02/20 Boulder/Denver
Investors Go With Gut Ahead of Microbiome Therapy Boom, Says Seventure 01/01/20 National
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines 12/24/19 National
Evotec CEO Discusses Ways to Make Drug R&D Faster and Better 12/24/19 National
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal 12/23/19 Boston
Healthcare AI Tech is Here, Now We Must Learn to Manage the Data 12/23/19 National
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More 12/20/19 National
Biogen Strikes Alzheimer’s Deal, Paying $45M for Ionis Tau Drug Rights 12/19/19 San Diego
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies 12/19/19 New York
Ring Therapeutics Launches to Expand Gene Therapy Viral Vector Options 12/19/19 Boston
ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies 12/18/19 Boulder/Denver
FTC Challenges PacBio Acquisition, Says Illumina is a “Monopolist” 12/18/19 San Diego
Zafgen’s Path Forward Is Reverse Merger With Chondrial Therapeutics 12/18/19 Boston
Orbiting Organoids: Research in Space to Unveil New Neurodegeneration Insight 12/18/19 National
ALS Fund Talks Investments and Strategy as it Kicks Off $100M Campaign 12/17/19 National
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s 12/17/19 Boston
Organovo’s Demise Offers Path for Tarveda to Join the Public Markets 12/16/19 San Diego
Wave Stock Crashes After Decision to Halt Duchenne Drug Studies 12/16/19 Boston
Cell Reprogramming Startup Bit Bio Inks Pact With Charles River 12/16/19 Boston
Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned 12/16/19 New York
Building a Better 3D Bioprinter: GE Healthcare and ASLS Combine Tech 12/16/19 Boston
Page 2 of 1957 « previous page · next page »